Alberto Vidal-Diez

Alberto Vidal-Diez

Auto-generated profile, based on publicly available information

Alberto Vidal-Diez

Department of Surgery and Cancer, Imperial College London, London, UK

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in The Lancet
Verified
Journal Article
Closed access
AKAlan Karthikesalingam
Alan Karthikesalingam
PHPeter J Holt
Peter J Holt
AVAlberto Vidal-Diez
Alberto Vidal-Diez
BOBaris A Ozdemir
Baris A Ozdemir
JPJan D Poloniecki
Jan D Poloniecki
MTMatthew M Thompson
Matthew M Thompson

1 March 2014 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
AMAnna Macready
Anna Macready
TGTrevor W George
Trevor W George
MCMary F Chong
Mary F Chong
DADauren S Alimbetov
Dauren S Alimbetov
YJYannan Jin
Yannan Jin
JLJulie A. Lovegrove
Julie A. Lovegrove
Background: Observed associations between increased fruit and vegetable (F&V) consumption, particularly those F&Vs that are rich in flavonoid

24 November 2016 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
AKAlan Karthikesalingam
Alan Karthikesalingam
AVAlberto Vidal-Diez
Alberto Vidal-Diez
PHPeter J. Holt
Peter J. Holt
ILIan M. Loftus
Ian M. Loftus
MSMarc L. Schermerhorn
Marc L. Schermerhorn
MTMatthew M. Thompson
Matthew M. Thompson
Thresholds for repair of abdominal aortic aneurysms vary considerably among countries. We examined differences between England and the United States in the frequency of aneurysm repair, the mean aneurysm diameter at the time of the procedure, and rates of aneurysm rupture and aneurysm-related death. Data on the frequency of repair of intact (nonruptured) abdominal aortic aneurysms, in-hospital mortality among patients who had undergone aneurysm repair, and rates of aneurysm rupture during the period from 2005 through 2012 were extracted from the Hospital Episode Statistics database in England and the U.S. Nationwide Inpatient Sample. Data on the aneurysm diameter at the time of repair were extracted from the U.K. National Vascular Registry (2014 data) and from the U.S. National Surgical Quality Improvement Program (2013 data). Aneurysm-related mortality during the period from 2005 through 2012 was determined from data obtained from the Centers for Disease Control and Prevention and the U.K. Office of National Statistics. Data were adjusted with the use of direct standardization or conditional logistic regression for differences between England and the United States with respect to population age and sex. During the period from 2005 through 2012, a total of 29,300 patients in England and 278,921 patients in the United States underwent repair of intact abdominal aortic aneurysms. Aneurysm repair was less common in England than in the United States (odds ratio, 0.49; 95% confidence interval [CI], 0.48 to 0.49; P<0.001), and aneurysm-related death was more common in England than in the United States (odds ratio, 3.60; 95% CI, 3.55 to 3.64; P<0.001). Hospitalization due to an aneurysm rupture occurred more frequently in England than in the United States (odds ratio, 2.23; 95% CI, 2.19 to 2.27; P<0.001), and the mean aneurysm diameter at the time of repair was larger in England (63.7 mm vs. 58.3 mm, P<0.001). We found a lower rate of repair of abdominal aortic aneurysms and a larger mean aneurysm diameter at the time of repair in England than in the United States and lower rates of aneurysm rupture and aneurysm-related death in the United States than in England. (Funded by the Circulation Foundation and others.)

15 July 2014 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
AAna Rodriguez-Mateos
Ana Rodriguez-Mateos
RGRaquel del Pino García
Raquel del Pino García
TGTrevor W. George
Trevor W. George
AVAlberto Vidal‐Diez
Alberto Vidal‐Diez
CHChristian Heiss
Christian Heiss
JSJeremy P. E. Spencer
Jeremy P. E. Spencer

15 July 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AKAlan Karthikesalingam
Alan Karthikesalingam
OAOmneya Attallah
Omneya Attallah
XMXianghong Ma
Xianghong Ma
SBSandeep Singh Bahia
Sandeep Singh Bahia
LTLuke Thompson
Luke Thompson
PHPeter J. Holt
Peter J. Holt
Lifelong surveillance after endovascular repair (EVAR) of abdominal aortic aneurysms (AAA) is considered mandatory to detect potentially life-threatening endograft complications. A minority of patients require reintervention but cannot be predictively identified by existing methods. This study aimed to improve the prediction of endograft complications and mortality, through the application of machine-learning techniques. Patients undergoing EVAR at 2 centres were studied from 2004-2010. Pre-operative aneurysm morphology was quantified and endograft complications were recorded up to 5 years following surgery. An artificial neural networks (ANN) approach was used to predict whether patients would be at low- or high-risk of endograft complications (aortic/limb) or mortality. Centre 1 data were used for training and centre 2 data for validation. ANN performance was assessed by Kaplan-Meier analysis to compare the incidence of aortic complications, limb complications, and mortality; in patients predicted to be low-risk, versus those predicted to be high-risk. 761 patients aged 75 +/- 7 years underwent EVAR. Mean follow-up was 36+/- 20 months. An ANN was created from morphological features including angulation/length/areas/diameters/volume/tortuosity of the aneurysm neck/sac/iliac segments. ANN models predicted endograft complications and mortality with excellent discrimination between a low-risk and high-risk group. In external validation, the 5-year rates of freedom from aortic complications, limb complications and mortality were 95.9% vs 67.9%; 99.3% vs 92.0%; and 87.9% vs 79.3% respectively (p<0.001) This study presents ANN models that stratify the 5-year risk of endograft complications or mortality using routinely available pre-operative data.

5 October 2016 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
SBS S Bahia
S S Bahia
AVA Vidal-Diez
A Vidal-Diez
SSS R K Seshasai
S R K Seshasai
ISI Shpitser
I Shpitser
JBJ R Brownrigg
J R Brownrigg
AKA Karthikesalingam
A Karthikesalingam
Background: Perioperative mortality is low for patients undergoing abdominal aortic aneurysm (AAA) repair, but long-term survival remains poor. Although patients diagnosed with AAA have a significant burden of cardiovascular disease and associated risk factors, there is limited understanding of the contribution of cardiovascular risk management to long-term survival. Methods: General practice records within The Health Improvement Network (THIN) were examined. Patients with a diagnosis of AAA and at least 1 year of registered medical history were identified from 2000 to 2012. Medical therapies for cardiovascular risk were classified as antiplatelet, statin or antihypertensive agents. Progression to death was investigated using the G-computation formula with time-dependent co-variables to account for differences in exposure to cardiovascular risk-modifying treatments and the confounding between exposure, co-morbidities and death. Results: Some 12 485 patients had a recorded diagnosis of AAA. From 2000 to 2012, prescription of medications that modify cardiovascular risk increased: from 26·6 to 76·7 per cent for statins, from 56·5 to 73·9 per cent for antiplatelet agents and from 75·3 to 84·0 per cent for antihypertensive drugs. Adjusted Kaplan–Meier curves demonstrated a better 5-year survival rate in patients receiving statins (68·4 versus 42·2 per cent), antiplatelet agents (63·6 versus 39·7 per cent) or antihypertensive agents (61·5 versus 39·1 per cent), compared with rates in patients not receiving each therapy. Conclusion: Appropriate risk factor modification could significantly reduce long-term mortality in patients with AAA. In the UK, up to 30 per cent of patients are not currently receiving these medications.